Experimental 'Off-the-Shelf' cell therapy targets tough blood cancer
Disease control
Recruiting now
This early-stage study is testing a new type of cell therapy for adults with multiple myeloma that has returned or stopped responding to standard treatments. The therapy uses immune cells (CAR-T cells) from donated umbilical cord blood, modified to attack two targets on cancer ce…
Phase: PHASE1 • Sponsor: Xi'an No.3 Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC